“…The ability to cover the mesh and attach it to the peritoneal surface with a hydrophilic absorbable material is likely to facilitate intraperitoneal onlay mesh repair strategies and reduce or eliminate intraabdominal adhesion formation, along with its attendant morbidity [2,6,8]. Several composite materials-including Parietex (Sofradim, Wrentham, MA, USA) and Sepramesh (Genzyme, Cambridge, MA, USA), as well as biological grafts such as Surgisis (Cook Surgical, Bloomington, IN, USA) and Alloderm (Life Cell, Branchburg, NJ, USA)-are currently available and marketed specifically for this purpose [13].…”